Trade Resources Company News Ortho Clinical Diagnostics Receives CE Mark Approval for Its New Diagnostic Blood Test

Ortho Clinical Diagnostics Receives CE Mark Approval for Its New Diagnostic Blood Test

Ortho Clinical Diagnostics has received CE mark approval for its new diagnostic blood test, Vitros Immunodiagnostic Product 25-OH Vitamin D Total assay.

The Vitros 25-OH Vitamin D Total assay is an one-step immunoassay designed to use on Vitros ECi/ECiQ Immunodiagnostic Systems, the Vitros 3600 Immunodiagnostic System, and the Vitros5600 Integrated System.

The results of 25-OH Vitamin D Total assay are used in the evaluation of vitamin D sufficiency and may be used in conjunction with other clinical or laboratory data to assist the clinician in patient management.

The assay in addition has a time to first result of 24 minutes which allows for improved timeliness of result reporting for higher-volume customers.

Ortho Clinical Diagnostics scientific affairs manager Lily Li said, "With CE Marking of the fully-automated VITROS Immunodiagnostic Product 25-OH Vitamin D Total Assay, OCD can now offer European customers a vitamin D test that provides equal detection of vitamin D2 and D3 for a more accurate evaluation of the patient's overall vitamin D status."

Recently, OCD filed a 510(k) application of Vitros 25-OH Vitamin D Total assay to the US Food and Drug Administration, which is still in pending approval.

Source: http://invitrodiagnostics.medicaldevices-business-review.com/news/ortho-clinical-new-vitros-vitamin-d-total-assay-wins-ce-mark-040612
Contribute Copyright Policy
Ortho Clinical New Vitros Vitamin D Total Assay Wins CE Mark